Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenously Administered REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intraveno ...